NCT02682823 Tocilizumab Real-Life Human Factors (RLHFs) Validation Study Status COMPLETED Phase PHASE4
NCT02679001 A Comparative Study to Observe the Effect of Concomitant Use of Corticosteroid Treatment in Rheumatoid Arthritis (RA) Participants Who Are Treated With a Tumor Necrosis Factor (TNF) Inhibitor or Tocilizumab (TCZ) as Their Second Biological Treatment. Status COMPLETED Phase N/A
NCT02675803 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of VAY736 in Rheumatoid Arthritis Patients Status COMPLETED Phase PHASE1
NCT02675426 A Study Comparing Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis on a Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response to csDMARDs Alone Status COMPLETED Phase PHASE3
NCT02671838 A Musculoskeletal Ultrasound Program to Improve Disease Modifying Anti-Rheumatic Drugs Adherence in Rheumatoid Arthritis Status COMPLETED Phase NA
NCT02668640 Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in China Status COMPLETED Phase N/A
NCT02665910 Multiple Doses Escalation Study of SHR0302 in Rheumatoid Arthritis (RA) Patients Status UNKNOWN Phase PHASE1
NCT02659150 Effect of Subcutaneous ACTEMRA on Inflamed Atherosclerotic Plaques in Patients With Rheumatoid Arthritis Status TERMINATED Phase PHASE4
NCT02658370 An Animated Home-based Physical Exercise Program as a Treatment Option for Patients With Rheumatoid Arthritis Status COMPLETED Phase NA
NCT02648035 EMBRACE-SC: Observational Study of Subcutaneous (SC) Tocilizumab Alone or in Combination With Conventional Disease-Modifying Antirheumatic Drugs (cDMARDs) in Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT02647762 CF101 Therapy Compared to Methotrexate Therapy for Active Rheumatoid Arthritis Status TERMINATED Phase PHASE3
NCT02644499 Comparison of Combination Disease Modifying Antirheumatic Drugs With Methotrexate Therapy in Early Rheumatoid Arthritis Status COMPLETED Phase PHASE4
NCT02643823 Human Umbilical Cord-Mesenchymal Stem Cells for Rheumatoid Arthritis Status UNKNOWN Phase PHASE1
NCT02638948 Efficacy and Safety Study of BMS-986142 in Patients With Moderate to Severe Rheumatoid Arthritis Status COMPLETED Phase PHASE2
NCT02638259 Comparative Efficacy and Safety Study of GP2015 and Enbrel® in Patients With Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT02636829 Validation of Self-administered Questionnaire for Assessing Calcium Intake in Patients With Multiple Sclerosis or Chronic Inflammatory Arthritis Status COMPLETED Phase NA